Please ensure Javascript is enabled for purposes of website accessibility

Amarin Pharma

Jun 9, 2026

SCOTUS News: Drugmaker’s ‘induced infringement’ suit comes up short

The U.S. Supreme Court ruled that Amarin Pharma failed to state a claim for induced infringement against Hikma Pharmaceuticals under federal patent law.

Verdicts & Settlements

See All Verdicts & Settlements

Opinion Digests

See All Digests